NONYE ONUOGU: Open Payments
NPI 1841721107 · HOUSTON, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$556 in 12 payments from 4 companies in 2025. Trend: 2023 $114 · 2024 $24 · 2025 $556
Food & beverage: $556
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 4 | $275 |
| Lilly USA, LLC | 3 | $157 |
| Novo Nordisk Inc | 3 | $75 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $49 |
Products named: AIRSUPRA, MOUNJARO, Wegovy, JARDIANCE, Ozempic.
Industry payments across TX — which companies pay providers there.
